Occipital nerve stimulation for intractable chronic cluster headache or migraine: A critical analysis of direct treatment costs and complications

Cephalalgia

Volumn 33, Issue 16, 2013, Pages 1283-1291

  Mueller, Oliver ^a   Diener, Hans Christoph ^a   Dammann, Philipp ^a   Rabe, Kasja ^a   Hagel, Vincent ^a   Sure, Ulrich ^a   Gaul, Charly ^a,b  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b Migraine and Headache Clinic   (Germany)

Author keywords

Chronic cluster headache; chronic migraine; complications; occipital nerve stimulation (ONS); outcome; treatment costs

Indexed keywords

DIHYDROERGOTAMINE; LITHIUM; TOPIRAMATE; VERAPAMIL;

ADULT; ARTICLE; CHRONIC CLUSTER HEADACHE; CLINICAL ARTICLE; DECUBITUS; DEVICE INFECTION; FEMALE; FOLLOW UP; HEALTH CARE COST; HOSPITALIZATION COST; HUMAN; MALE; MIGRAINE; NAUSEA; NERVE STIMULATION; NEUROMODULATION; OCCIPITAL NERVE STIMULATION; PATIENT SELECTION; TREATMENT RESPONSE;

CHRONIC CLUSTER HEADACHE; CHRONIC MIGRAINE; COMPLICATIONS; OCCIPITAL NERVE STIMULATION (ONS); OUTCOME; TREATMENT COSTS;

ADULT; CLUSTER HEADACHE; ELECTRIC STIMULATION THERAPY; ELECTRODES, IMPLANTED; FEMALE; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; POSTOPERATIVE COMPLICATIONS;

EID: 84887836135     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1177/0333102413493193     Document Type: Article

References (43)

1. Robbins MS, Lipton RB. The epidemiology of primary headache disorders. Semin Neurol. 2010 ; 30: 107-119
2. Gaul C, Finken J, Biermann J, et al. Treatment costs and indirect costs of cluster headache: A health economics analysis. Cephalalgia. 2011 ; 31: 1664-1672
3. Wang SJ, Wang PJ, Fuh JL, et al. Comparisons of disability, quality of life, and resource use between chronic and episodic migraineurs: A clinic-based study in Taiwan. Cephalalgia. 2013 ; 33: 171-181
4. Bigal ME, Serrano D, Reed M, et al. Chronic migraine in the population: Burden, diagnosis, and satisfaction with treatment. Neurology. 2008 ; 71: 559-566
5. Munakata J, Hazard E, Serrano D, et al. Economic burden of transformed migraine: Results from the American Migraine Prevalence and Prevention (AMPP) Study. Headache. 2009 ; 49: 498-508
6. Bussone G, Usai S, Grazzi L, et al. Disability and quality of life in different primary headaches: Results from Italian studies. Neurol Sci. 2004 ;: S105 - S107
7. Diener HC, Holle D, Dodick D. Treatment of chronic migraine. Curr Pain Headache Rep. 2010 ; 15: 64-69
8. Diener HC, Dodick DW, Goadsby PJ, et al. Utility of topiramate for the treatment of patients with chronic migraine in the presence or absence of acute medication overuse. Cephalalgia. 2009 ; 29: 1021-1027
9. Diener HC, Dodick DW, Aurora SK, et al. OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial. Cephalalgia. 2010 ; 30: 804-814
10. Diener HC, Bussone G, de Liano H, et al. Placebo-controlled comparison of effervescent acetylsalicylic acid, sumatriptan and ibuprofen in the treatment of migraine attacks. Cephalalgia. 2004 ; 24: 947-954 (Pubitemid 39471921)
11. Gaul C, Diener HC, Müller OM. Cluster headache: Clinical features and therapeutic options. Dtsch Arztebl Int. 2011 ; 108: 543-549
12. Stokes M, Becker WJ, Lipton RB, et al. Cost of health care among patients with chronic and episodic migraine in Canada and the USA: Results from the International Burden of Migraine Study (IBMS). Headache. 2011 ; 51: 1058-1077
13. Bloudek LM, Stokes M, Buse DC, et al. Cost of healthcare for patients with migraine in five European countries: Results from the International Burden of Migraine Study (IBMS). J Headache Pain. 2012 ; 13: 361-378
14. Irimia P, Palma JA, Fernandez-Torron R, et al. Refractory migraine in a headache clinic population. BMC Neurol. 2011 ; 11: 94-94
15. Leone M, Franzini A, Cecchini AP, et al. Hypothalamic deep brain stimulation in the treatment of chronic cluster headache. Ther Adv Neurol Disord. 2010 ; 3: 187-195
16. Leone M, Franzini A, Proietti Cecchini A, et al. Deep brain stimulation in trigeminal autonomic cephalalgias. Neurotherapeutics. 2010 ; 7: 220-228
17. Magis D, Gerardy PY, Remacle JM, et al. Sustained effectiveness of occipital nerve stimulation in drug-resistant chronic cluster headache. Headache. 2011 ; 51: 1191-1201
18. Weiner RL, Reed KL. Peripheral neuromodulation for control of intractable occipital neuralgia. Neuromodulation. 1999 ; 2: 217-221 (Pubitemid 29409598)
19. Popeney CA, Alo KM. Peripheral neurostimulation for the treatment of chronic, disabling transformed migraine. Headache. 2003 ; 43: 369-375 (Pubitemid 36417767)
20. Burns B, Watkins L, Goadsby PJ. Treatment of medically intractable cluster headache by occipital nerve stimulation: Long-term follow-up of eight patients. Lancet. 2007 ; 369: 1099-1106 (Pubitemid 46483638)
21. Mueller OM, Gaul C, Katsarava Z, et al. Occipital nerve stimulation for the treatment of chronic cluster headache - lessons learned from 18 months experience. Cen Eur Neurosurg. 2011 ; 72: 84-89
22. Magis D, Schoenen J. Advances and challenges in neurostimulation for headaches. Lancet Neurol. 2012 ; 11: 708-719
23. The International Classification of Headache Disorders: 2nd edition. Cephalalgia 2004; 24 (Suppl 1): 9-160.
24. May A, Jürgens TP. Diagnosis and therapy of chronic headaches [in German]. Nervenarzt. 2010 ; 81: 1007-1016; quiz 1017-1018
25. Müller OM, Gaul C, Katsarava Z, et al. Bilateral occipital nerve stimulation for the treatment of chronic cluster headache: Case series and initiation of a prospective study [in German]. Fortschr Neurol Psychiatr. 2010 ; 78: 709-714
26. Nagy AJ, Gandhi S, Bhola R, et al. Intravenous dihydroergotamine for inpatient management of refractory primary headaches. Neurology. 2011 ; 77: 1827-1832
27. Sallam H, McNearney TA, Doshi D, et al. Transcutaneous electrical nerve stimulation (TENS) improves upper GI symptoms and balances the sympathovagal activity in scleroderma patients. Dig Dis Sci. 2007 ; 52: 1329-1337 (Pubitemid 46626166)
28. Matharu MS, Bartsch T, Ward N, et al. Central neuromodulation in chronic migraine patients with suboccipital stimulators: A PET study. Brain. 2004 ; 127: 220-230 (Pubitemid 38055361)
29. Magis D, Allena M, Bolla M, et al. Occipital nerve stimulation for drug-resistant chronic cluster headache: A prospective pilot study. Lancet Neurol. 2007 ; 6: 314-321 (Pubitemid 46389615)
30. Leone M, Proietti Cecchini A, Franzini A, et al. Lessons from 8 years' experience of hypothalamic stimulation in cluster headache. Cephalalgia. 2008 ; 28: 787-797; discussion 798
31. Silberstein SD, Dodick DW, Saper J, et al. Safety and efficacy of peripheral nerve stimulation of the occipital nerves for the management of chronic migraine: Results from a randomized, multicenter, double-blinded, controlled study. Cephalalgia. 2012 ; 32: 1165-1179
32. Saper JR, Dodick DW, Silberstein SD, et al. Occipital nerve stimulation for the treatment of intractable chronic migraine headache: ONSTIM feasibility study. Cephalalgia. 2011 ; 31: 271-285
33. Jasper JF, Hayek SM. Implanted occipital nerve stimulators. Pain Physician. 2008 ; 11: 187-200 (Pubitemid 351546230)
34. Burns B, Watkins L, Goadsby PJ. Treatment of intractable chronic cluster headache by occipital nerve stimulation in 14 patients. Neurology. 2009 ; 72: 341-345
35. Schwedt TJ, Dodick DW, Hentz J, et al. Occipital nerve stimulation for chronic headache - long-term safety and efficacy. Cephalalgia. 2007 ; 27: 153-157 (Pubitemid 46169441)
36. Leone M, Franzini A, Cecchini AP, et al. Stimulation of occipital nerve for drug-resistant chronic cluster headache. Lancet Neurol. 2007 ; 6: 289-291 (Pubitemid 46367940)
37. Paemeleire K, Bartsch T. Occipital nerve stimulation for headache disorders. Neurotherapeutics. 2010 ; 7: 213-219
38. Falowski S, Wang D, Sabesan A, et al. Occipital nerve stimulator systems: Review of complications and surgical techniques. Neuromodulation. 2010 ; 13: 121-125
39. Forbes SS, McLean RF. Review article: The anesthesiologist's role in the prevention of surgical site infections. Can J Anaesth. 2013 ; 60: 176-183
40. Weaver FM, Stroupe KT, Cao L, et al. Parkinson's disease medication use and costs following deep brain stimulation. Mov Disord. 2012 ; 27: 1398-1403
41. Valldeoriola F, Morsi O, Tolosa E, et al. Prospective comparative study on cost-effectiveness of subthalamic stimulation and best medical treatment in advanced Parkinson's disease. Mov Disord. 2007 ; 22: 2183-2191
42. Owens GM, Olvey EL, Skrepnek GH, et al. Perspectives for managed care organizations on the burden of multiple sclerosis and the cost-benefits of disease-modifying therapies. J Manag Care Pharm. 2013 ; 19: S41 - S53
43. Karampampa K, Gustavsson A, Miltenburger C, et al. Treatment experience, burden and unmet needs (TRIBUNE) in MS study: Results from Germany. Mult Scler. 2012 ; 18: 23-27